We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$3.3B
AUM Growth
+$481M
Cap. Flow
+$512M
Cap. Flow %
15.52%
Top 10 Hldgs %
30.72%
Holding
1,380
New
403
Increased
148
Reduced
188
Closed
428

Sector Composition

Rank Sector Weight
1 Healthcare 3.28%
2 Communication Services 1.55%
3 Technology 0.91%
4 Consumer Discretionary 0.74%
5 Financials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSLY icon
676
CALL
Fastly Inc
FSLY
$3.24B
$344K 0.01%
8,500
-15,000
-64% -$692K
DQ
677
Daqo New Energy
DQ
$810M
$342K 0.01%
+6,000
New +$359K
KDP icon
678
CALL
Keurig Dr Pepper
KDP
$42.8B
$342K 0.01%
+10,000
New +$350K
INTC icon
679
Intel
INTC
$413B
$341K 0.01%
6,400
NKTR icon
680
CALL
Nektar Therapeutics
NKTR
$2.39B
$341K 0.01%
+1,267
New +$305K
DB icon
681
CALL
Deutsche Bank
DB
$66.6B
$339K 0.01%
26,700
BCRX icon
682
CALL
BioCryst Pharmaceuticals
BCRX
$2.42B
$338K 0.01%
+23,500
New +$371K
OPLN
683
CALL
Openlane
OPLN
$4.28B
$338K 0.01%
20,600
+600
+3% +$10.1K
CORT icon
684
Corcept Therapeutics
CORT
$9.98B
$337K 0.01%
17,100
-63,400
-79% -$1.33M
RIGL icon
685
Rigel Pharmaceuticals
RIGL
$723M
$334K 0.01%
9,196
+5,196
+130% +$205K
RH icon
686
RH
RH
$3.33B
$333K 0.01%
500
-100
-17% -$68.8K
IONS icon
687
CALL
Ionis Pharmaceuticals
IONS
$8.93B
$332K 0.01%
9,900
-21,100
-68% -$795K
AXSM icon
688
CALL
Axsome Therapeutics
AXSM
$11.7B
$330K 0.01%
+10,000
New +$390K
FTAI icon
689
PUT
FTAI Aviation
FTAI
$20.2B
$330K 0.01%
15,223
-8,197
-35% -$196K
TJX icon
690
PUT
TJX Companies
TJX
$179B
$330K 0.01%
+5,000
New +$349K
CPE
691
PUT
DELISTED
Callon Petroleum Company
CPE
$329K 0.01%
6,700
-20,000
-75% -$774K
PPD
692
CALL
DELISTED
PPD, Inc. Common Stock
PPD
$328K 0.01%
7,000
CLNE icon
693
CALL
Clean Energy Fuels
CLNE
$416M
$326K 0.01%
40,000
-10,000
-20% -$79.6K
PFGC icon
694
CALL
Performance Food Group
PFGC
$18.3B
$325K 0.01%
+7,000
New +$322K
MAG
695
PUT
DELISTED
MAG Silver
MAG
$324K 0.01%
20,000
QURE icon
696
PUT
uniQure
QURE
$2.78B
$320K 0.01%
+10,000
New +$305K
SWTX
697
CALL
DELISTED
SpringWorks Therapeutics
SWTX
$317K 0.01%
+5,000
New +$385K
LEV
698
CALL
DELISTED
The Lion Electric Company
LEV
$316K 0.01%
25,000
-255,500
-91% -$3.57M
RPTX
699
PUT
DELISTED
Repare Therapeutics
RPTX
$315K 0.01%
+12,000
New +$388K
RAPT
700
CALL
DELISTED
RAPT Therapeutics
RAPT
$311K 0.01%
1,250
-7,563
-86% -$2M

Similar funds

SG3 Management's Q3 2021 Portfolio in Review

As of Q3 2021, SG3 Management held 1,380 positions worth $3.3B, up 17% from $2.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

SG3 Management deployed $512M of net new capital in Q3 2021, opening 403 new positions and adding to 148 existing holdings. Its largest new stake was Alphabet (Google) Class C: 300,000 shares worth $40M.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.3% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Bank of America, an estimated $4.85M trimmed.

  • SG3 Management's largest Q3 2021 buy was Alphabet (Google) Class C: 300,000 shares worth $40M.
  • SG3 Management added most to Bausch Health in Q3 2021, an estimated $7.4M increase.
  • SG3 Management's biggest Q3 2021 reduction was Bank of America, cutting an estimated $4.85M.
  • SG3 Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $24.4M.
  • SG3 Management's ten largest holdings make up 31% of its $3.3B portfolio in Q3 2021.
  • SG3 Management opened 403 new positions and closed 428 in Q3 2021.
  • SG3 Management's portfolio value rose 17% quarter-over-quarter to $3.3B.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.